Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

EMI reform quadruples the scaleup thresholds

3 min read
16:30UTC

Gross-assets limit jumps from £30m to £120m. Employee headroom doubles from 250 to 500. The share-option pool doubles to £6m. Most of this unlocks at Series B and C, not seed.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

EMI's quadrupled limits help Series B+ retention while the sub-£2m tier hollows out at exactly the same speed.

Enterprise Management Incentives (EMI) reform took effect on 6 April 2026. The gross-assets test rose from £30m to £120m, the employee limit doubled from 250 to 500, and the share-option pool doubled from £3m to £6m. Lifetime company investment limits under EIS and VCT were also doubled to £24m. HM Treasury estimates the package unlocks roughly £100m a year across around 1,800 UK scaleups, equivalent to about 70,000 employees who can now receive tax-advantaged share options their employer's size previously excluded.⁠1

EMI lets qualifying small companies grant employees share options on which capital gains tax is charged at entrepreneurs' rates rather than as income, delivering materially higher net proceeds than cash bonuses for comparable employer cost. The old £30m gross-assets limit was the binding ceiling: scaleups breaching it had to drop EMI, typically at Series B or C, and replace it with non-tax-advantaged schemes. The new £120m ceiling lets a 400-person company at a £100m valuation keep offering tax-advantaged options through its growth phase; that was the policy intent.

The reform landed alongside the VCT relief cut. Read together, the two moves redistribute tax incentive away from pooled retail risk capital and toward direct scaleup employee compensation. That is coherent for companies of 250-500 staff raising above £5m; it does nothing for pre-revenue founders looking for a £500,000 cheque. The British Business Bank's direct mandate starts at £5m, and the UK grant-award picture continues to consolidate into fewer, bigger cheques.

CFOs at 250-500-headcount scaleups can reset option schemes at the next board meeting under the new £120m ceiling. Pre-Series-A founders see no change: the reform touches nothing in the capital environment below £5m. The policy machinery still has a visible gap between £250k and £2m, and none of the 6 April instruments reaches it.

Deep Analysis

In plain English

EMI stands for Enterprise Management Incentives. It is a government scheme that lets small British companies give their employees share options with a generous tax treatment, so that when the company succeeds, the employees share in the value they helped create. The problem was that the rules had a size limit; companies with assets over £30m could not use it. Since the late 1990s, inflation has meant that many growing technology companies hit that limit before they were anywhere near the public markets or an acquisition. The government has now raised the limit to £120m and doubled the total option pool, so more scaleup companies can keep using the scheme as they grow.

Deep Analysis
Root Causes

The 2022 gilt-market crisis pushed UK risk-free returns from near-zero to 4-5%, materially raising the opportunity cost for early-stage employees accepting below-market salaries in exchange for equity; the EMI reform responds to a talent-market shift rather than an innovation-policy shift, because the retention problem at Series A to C became acute specifically after 2022 when deferred compensation (options) started competing with observable, liquid alternatives.

The post-Brexit loss of the EU's pan-European patent court (before the UK's eventual accession to the Unified Patent Court in February 2023) created a period of IP uncertainty for scaleups filing multi-jurisdiction patents; that uncertainty increased the perceived risk of equity compensation for engineers, making higher option-pool values necessary to achieve the same retention effect.

What could happen next?
  • Consequence

    HMRC's estimated 14-month advance assurance backlog means the April 2026 reform will not be practically available to most scaleups until mid-2027; companies that need EMI options to close Series B hiring rounds before then will face a regulatory lag that partially negates the policy's intended effect.

  • Opportunity

    UK companies between £30m and £120m in gross assets that could not previously offer EMI options; estimated at 800-1,000 companies per Beauhurst's 2025 scaleup census; can now restructure their compensation mix, potentially reducing cash salary burn by 15-20% at the senior engineering level.

Sources:GOV.UK (HM Treasury / DSIT)·GOV.UK (HM Treasury / DSIT)·GOV.UK (HM Treasury / DSIT)
Mentions:HM Treasury →Enterprise Investment Scheme →Venture Capital Trusts →HMRC →Institute for Government →British Business Bank →Beauhurst →Enterprise Management Incentives →
First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

GOV.UK (HM Treasury / DSIT)· 22 Apr 2026
Read original →
Causes and effects
Caused by
Business Bank begins direct startup investment
The EMI reform, reported in the same Industrial Strategy Q1 Update as the BBB direct mandate (ID:2343), targets scaleups of 250-500 employees that BBB's £5m minimum ticket also serves.
Occurred 6 Apr 2026
Read story →
UK grant count falls to 10-year low
EMI reform targets scaleups while grant award counts are already at a 10-year low (ID:2351), highlighting a structural gap between seed and scaleup-tier instruments.
Occurred 1 Jan 2026
Read story →
This Event
EMI reform quadruples the scaleup thresholds
The EMI reform and the simultaneous VCT cut together redistribute tax incentive away from pooled retail seed capital and toward scaleup employee compensation, with no bridging instrument for the £250k-£2m tier in between.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.